Article info
Letter
The use of the tumour necrosis factor antagonist infliximab in heart transplant recipients: two case reports
- Professor D G Arkfeld, University of Southern California, Keck School of Medicine, Department of Medicine – Rheumatology, 2011 Zonal Avenue, HMR 711, Los Angeles, CA 90033, USA; arkfeld{at}usc.edu
Citation
The use of the tumour necrosis factor antagonist infliximab in heart transplant recipients: two case reports
Publication history
- Accepted May 21, 2007
- First published October 12, 2007.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2007 BMJ Publishing Group Ltd and European League Against Rheumatism